SCHEMBL7798914

SCHEMBL7798914

O=CNC(CSSCC(NC=O)C(=O)NCCc1ccccc1)C(=O)NCCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.48
PLAAT5 Q96KN8 4/20 0.47
PLAAT4 Q9UL19 4/20 0.47
ALDH1A1 P00352 3/20 0.46
TAAR1 Q96RJ0 1/20 0.46
CA12 O43570 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
PLAAT3 P53816 3/20 0.45
PLAAT2 Q9NWW9 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 2/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HPGD P15428 1/20 0.44
EPHX1 P07099 1/20 0.44
MMP1 P03956 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799219 0.86 MME (0.49) ALDH1A1CA12CA2CA9KMT2A
SCHEMBL7793435 0.81 CA12 (0.52) POLBALDH1A1CA12CA2CA9
SCHEMBL7793390 0.80 KMT2A (0.57) ALDH1A1CA12CA2CA9NPC1
SCHEMBL7798918 0.79 POLB (0.42) POLBALDH1A1CA2SMN1; SMN2NPC1
SCHEMBL7799262 0.78 POLB (0.52) POLBCA12CA2CA9KMT2A
SCHEMBL7793406 0.78 POLB (0.49) POLBCA12CA2CA9KMT2A
SCHEMBL7793404 0.77 F10 (0.48) POLBCA12CA2CA9KMT2A
SCHEMBL7800969 0.77 MMP2 (0.55) POLBALDH1A1CA12CA2CA9
SCHEMBL7803203 0.77 POLB (0.51) POLBCA2KMT2ACYP2D6CYP2C9
SCHEMBL7793447 0.77 MMP1 (0.64) POLBPLAAT5PLAAT4ALDH1A1PLAAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed